Skip to main content

Making Peptide Purification Green without Forfeiting Productivity.

While green solvents like ethanol and DMC are better for the planet, they typically suffer from lower chromatographic resolution in traditional setups. This has resulted in a trade-off of choosing sustainability, or choosing high yield.

The whitepaper Counter-Current Chromatography Enables Use of Green Solvents for Productive Peptide Purification Processes shows how using Multi-column Counter-current Solvent Gradient Purification (MCSGP) can overcome the inefficiencies of eco-friendly mobile phases.

𝗧𝗵𝗲 𝗥𝗲𝘀𝘂𝗹𝘁𝘀
This whitepaper shows the results utilizing MCSGP on two real-world medicines (Tirzepatide and Tetracosactide). By combining the eco-friendly cleaners with this multi-column system, the results were:
► Tirzepatide (using Ethanol/Acetic Acid): Achieved 88.1% yield at 89.0% purity, while boosting productivity to 6.3 g/L_resin/h.
► Tetracosactide (using DMC/Acetic Acid): Reached a remarkable 93.8% yield at 94.0% purity—proving that green chromatography can meet or even exceed traditional batch performance.

Learn more about phasing out forever chemicals, shrinking the waste footprint, and hitting high target yields.

Click to read the whitepaper.

Posted on July 16, 2026.

Related Posts

September 4, 2026

YMC America Brings U.S.-Supplied ASME U-Stamped DAC Columns to Pharmaceutical Manufacturers

YMC America will be the First U.S.-Based Supplier of ASME U-Stamped DAC Columns. The company’s DAC columns support pharmaceutical and biopharmaceutical customers from process development through commercial production. Systems are used in laboratory, pilot, and production-scale chromatography applications, including purification processes for peptides, oligonucleotides, and small-molecule APIs.

September 10, 2026

Analytical Technologies for Therapeutic Peptides

Therapeutic peptides are an emerging class of active pharmaceutical ingredients that, together with other classes of bioproducts, have been attracting considerable attention due to their unique advantages. Their structure is based on well-defined amino acid sequences that may or may not contain structural modifications, resulting in molecules that generally range from 500 to 5000 Da. Currently, many examples can be used as medicines related to hormones, growth factors, neurotransmitters, among others.

September 9, 2026

Tecnologias Analíticas para Peptídeos Terapêuticos- Portuguese

Os peptídeos terapêuticos são uma classe emergente de insumos farmacêuticos ativos que, juntamente com outras classes de bioprodutos, vêm despertando grande interesse devido às suas vantagens únicas.

Designed and developed by